Affiliation:
1. Malaria Cell Biology, Molecular Biology and Immunology, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany
2. Infectious Disease Epidemiology Department, Epidemiology and Diagnostics, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany
3. German Centre for Infection Research (DZIF), Partner Site Hamburg-Luebeck-Borstel-Riems, Hamburg, Germany
Abstract
ABSTRACT
Reduced susceptibility to ART, the first-line treatment against malaria, is common in South East Asia (SEA). It is associated with point mutations, mostly in
kelch13
(
k13
) but also in other genes, like
ubp1
. K13 and its compartment neighbors (KICs), including UBP1, are involved in endocytosis of host cell cytosol. We tested 135 mutations in KICs but none conferred ART resistance. Double mutations of
k13
C580Y with
k13
R539T or
k13
C580Y with
ubp1
R3138H, did also not increase resistance. In contrast,
k13
C580Y parasites subjected to consecutive RSAs did, but the
k13
sequence was not altered. Using isogenic parasites with different
k13
mutations, we found correlations between K13 protein amount, resistance, and fitness cost. Titration of K13 and KIC7 indicated that the cellular levels of these proteins determined resistance through the rate of endocytosis. While fitness cost of
k13
mutations correlated with ART resistance,
ubp1
R3138H caused a disproportionately higher fitness cost.
IMPORTANCE
Parasites with lowered sensitivity to artemisinin-based drugs are becoming widespread. However, even in these “resistant” parasites not all parasites survive treatment. We found that the proportion of surviving parasites correlates with the fitness cost of resistance-inducing mutations which might indicate that the growth disadvantages prevents resistance levels where all parasites survive treatment. We also found that combining two common resistance mutations did not increase resistance levels. However, selection through repeated ART-exposure did, even-though the known resistance genes, including
k13
, were not further altered, suggesting other causes of increased resistance. We also observed a disproportionally high fitness cost of a resistance mutation in resistance gene
ubp1
. Such high fitness costs may explain why mutations in
ubp1
and other genes functioning in the same pathway as
k13
are rare. This highlights that
k13
mutations are unique in their ability to cause resistance at a comparably low fitness cost.
Funder
Vereinigung der Freunde des Tropeninstituts Hamburg e.V.
German Center for Infection Research
Wellcome Trust
EC | European Research Council
Publisher
American Society for Microbiology